Nitroglycerin, also known as glyceryl trinitrate, is an organic nitrate and a vasodilating agent that was first discovered in 1847. Originally used to dynamite, its antianginal effects were identified in the late 1860s after it produced headaches in factory workers while workers with angina pectoris or heart failure experienced relief from chest pain. Its u...
Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.
...
Guangzhou Red cross hospital, Guangzhou, Guangdong, China
Jin-Tae Kim, Seoul, Korea, Republic of
Kasr Al Ainy, Cairo, Egypt
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
Hermina Heart Center, Jakarta Pusat, DKI Jakarta, Indonesia
Janos Vag, Budapest, Hungary
Mansoura university hospital, Mansourah, Dakahlia, Egypt
Department of obstetrics and gynaecology, faculty of medicine, Ain shams university, Cairo, Egypt
Mount Sinai Hospital, Toronto, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.